Next Article in Journal
Aging’s Effect on Working Memory—Modality Comparison
Previous Article in Journal
Using Macrophage Polarization in Human Platelet Lysate to Test the Immunomodulatory Potential of Cells for Clinical Use
Previous Article in Special Issue
Dimethyl Fumarate as Potential Treatment for Alzheimer’s Disease: Rationale and Clinical Trial Design
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 12
Issue 4
10.3390/biomedicines12040834
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Biomedicines 2022, 10(5), 1073.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: D’Amico et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson’s Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073

by
Ramona D’Amico
1,†,
Enrico Gugliandolo
2,†,
Rosalba Siracusa
1,
Marika Cordaro
3,
Tiziana Genovese
1,
Alessio Filippo Peritore
1,
Rosalia Crupi
2,
Livia Interdonato
1,
Davide Di Paola
1,
Salvatore Cuzzocrea
1,*,
Roberta Fusco
4,*,
Daniela Impellizzeri
1,‡ and
Rosanna Di Paola
2,‡
1
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy
2
Department of Veterinary Science, University of Messina, 98168 Messina, Italy
3
Department of Biomedical, Dental and Morphological and Functional Imaging, University of Messina, 98125 Messina, Italy
4
Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
‡
Daniela Impellizzeri and Rosanna Di Paola share senior authorship.
Biomedicines 2024, 12(4), 834; https://doi.org/10.3390/biomedicines12040834
Submission received: 12 March 2024 / Revised: 2 April 2024 / Accepted: 4 April 2024 / Published: 10 April 2024
(This article belongs to the Special Issue Molecular Pathology and Biomarkers of Neurodegenerative Diseases)
Browse Figures
Versions Notes
Errors in Figures
In the original publication [1] for panels in Figure 2 and Figure 3, the authors unintentionally assembled some wrong figures. In Figure 2, in the group MPTP + PFOS, they inadvertently attached the wrong picture, and in Figure 3, in the groups Sham + CP and Sham + DEP, they made a copy and paste of the same figure. The authors checked all the data in their laboratory, and they were able to find the original photos and prepare a revised figure using an appropriate representative image from their database belonging to the experimental groups in question. The authors apologize for any inconvenience caused by this oversight. These errors do not affect the results and conclusions published in the article. The new Figure 2 and Figure 3 appear below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. D’Amico, R.; Gugliandolo, E.; Siracusa, R.; Cordaro, M.; Genovese, T.; Peritore, A.F.; Crupi, R.; Interdonato, L.; Di Paola, D.; Cuzzocrea, S.; et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson’s Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073. [Google Scholar] [CrossRef] [PubMed]
Biomedicines 12 00834 g002
Figure 2. Immunohistochemical evaluation in the midbrain for TH expression (A). Graphical quantification of TH expression (B). Western blots and densitometric analysis of TH (C) and DAT (D). A 20× magnification is shown (100-µm scale bar). A demonstrative blot of lysates with a densitometric analysis for all animals is shown. Data are expressed as the mean ± SEM of N = 6 mice/group. * p < 0.05 vs. sham; ** p < 0.01 vs. sham; *** p < 0.001 vs. sham; # p < 0.05 vs. MPTP; ## p < 0.01 vs. MPTP; ### p < 0.001 vs. MPTP.
Figure 2. Immunohistochemical evaluation in the midbrain for TH expression (A). Graphical quantification of TH expression (B). Western blots and densitometric analysis of TH (C) and DAT (D). A 20× magnification is shown (100-µm scale bar). A demonstrative blot of lysates with a densitometric analysis for all animals is shown. Data are expressed as the mean ± SEM of N = 6 mice/group. * p < 0.05 vs. sham; ** p < 0.01 vs. sham; *** p < 0.001 vs. sham; # p < 0.05 vs. MPTP; ## p < 0.01 vs. MPTP; ### p < 0.001 vs. MPTP.
Biomedicines 12 00834 g002
Biomedicines 12 00834 g003
Figure 3. Immunohistochemical evaluation for α-syn expression (A). Graphical quantification of α-syn expression (B). Western blot and densitometric analysis of α-syn (C). A 40× magnification is shown (75-µm scale bar). A demonstrative blot of lysates with a densitometric analysis for all animals is shown. Data are expressed as the mean ± SEM of N = 6 mice/group. * p < 0.05 vs. sham; ** p < 0.01 vs. sham; *** p < 0.001 vs. sham; # p < 0.05 vs. MPTP; ## p < 0.01 vs. MPTP; ### p < 0.001 vs. MPTP.
Figure 3. Immunohistochemical evaluation for α-syn expression (A). Graphical quantification of α-syn expression (B). Western blot and densitometric analysis of α-syn (C). A 40× magnification is shown (75-µm scale bar). A demonstrative blot of lysates with a densitometric analysis for all animals is shown. Data are expressed as the mean ± SEM of N = 6 mice/group. * p < 0.05 vs. sham; ** p < 0.01 vs. sham; *** p < 0.001 vs. sham; # p < 0.05 vs. MPTP; ## p < 0.01 vs. MPTP; ### p < 0.001 vs. MPTP.
Biomedicines 12 00834 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

D’Amico, R.; Gugliandolo, E.; Siracusa, R.; Cordaro, M.; Genovese, T.; Peritore, A.F.; Crupi, R.; Interdonato, L.; Di Paola, D.; Cuzzocrea, S.; et al. Correction: D’Amico et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson’s Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073. Biomedicines 2024, 12, 834. https://doi.org/10.3390/biomedicines12040834

AMA Style

D’Amico R, Gugliandolo E, Siracusa R, Cordaro M, Genovese T, Peritore AF, Crupi R, Interdonato L, Di Paola D, Cuzzocrea S, et al. Correction: D’Amico et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson’s Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073. Biomedicines. 2024; 12(4):834. https://doi.org/10.3390/biomedicines12040834

Chicago/Turabian Style

D’Amico, Ramona, Enrico Gugliandolo, Rosalba Siracusa, Marika Cordaro, Tiziana Genovese, Alessio Filippo Peritore, Rosalia Crupi, Livia Interdonato, Davide Di Paola, Salvatore Cuzzocrea, and et al. 2024. "Correction: D’Amico et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson’s Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073" Biomedicines 12, no. 4: 834. https://doi.org/10.3390/biomedicines12040834

APA Style

D’Amico, R., Gugliandolo, E., Siracusa, R., Cordaro, M., Genovese, T., Peritore, A. F., Crupi, R., Interdonato, L., Di Paola, D., Cuzzocrea, S., Fusco, R., Impellizzeri, D., & Di Paola, R. (2024). Correction: D’Amico et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson’s Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073. Biomedicines, 12(4), 834. https://doi.org/10.3390/biomedicines12040834

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop